ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice.

Silvere Pagant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.